These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7614687)

  • 1. A 32P-postlabelling assay for the detection of alkylphosphotriesters in DNA.
    Saris CP; Damman SJ; van den Ende AM; Westra JG; den Engelse L
    Carcinogenesis; 1995 Jul; 16(7):1543-8. PubMed ID: 7614687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of DNA alkylphosphotriesters by 32P postlabeling: evidence for the nonrandom manifestation of phosphotriester lesions in vivo.
    Guichard Y; Jones GD; Farmer PB
    Cancer Res; 2000 Mar; 60(5):1276-82. PubMed ID: 10728687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of platinum-DNA adducts by 32P-postlabelling.
    Blommaert FA; Saris CP
    Nucleic Acids Res; 1995 Apr; 23(8):1300-6. PubMed ID: 7753620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabelling analysis of alkylphosphotriesters in DNA.
    Saris CP; Damman SJ; van den Ende AM; Westra JG; den Engelse L
    IARC Sci Publ; 1993; (124):127-32. PubMed ID: 8225475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabelling of alkylated thymidines using Epstein-Barr virus encoded thymidine kinase.
    Povey AC; Cooper DP; Littler E
    Carcinogenesis; 1991 Apr; 12(4):709-12. PubMed ID: 1849471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further development of 32P-postlabeling for the detection of alkylphosphotriesters: evidence for the long-term nonrandom persistence of ethyl-phosphotriester adducts in vivo.
    Le Pla RC; Guichard Y; Bowman KJ; Gaskell M; Farmer PB; Jones GD
    Chem Res Toxicol; 2004 Nov; 17(11):1491-500. PubMed ID: 15540947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a 32P-postlabelling method for the analysis of 2'-deoxyguanosine-3'-monophosphate and DNA adducts of methylglyoxal.
    Vaca CE; Fang JL; Conradi M; Hou SM
    Carcinogenesis; 1994 Sep; 15(9):1887-94. PubMed ID: 7923582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K; Anna L; Rudnai P; Schoket B
    Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA.
    Fang JL; Vaca CE
    Carcinogenesis; 1995 Sep; 16(9):2177-85. PubMed ID: 7554072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of oligodeoxyribonucleotides containing an ethylated internucleotide phosphate.
    Weinfeld M; Livingston DC
    Biochemistry; 1986 Sep; 25(18):5083-91. PubMed ID: 3768334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
    Vaca CE; Löfgren M; Hemminki K
    Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of two major ethylated deoxyguanosine adducts by high performance liquid chromatography, electrospray mass spectrometry, and 32P-postlabeling. Development of an approach for detection of phosphotriesters.
    Singh R; Sweetman GM; Farmer PB; Shuker DE; Rich KJ
    Chem Res Toxicol; 1997 Jan; 10(1):70-7. PubMed ID: 9074805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabelling of 2-hydroxyethylated, ethylated and methylated adducts of 2'-deoxyguanosine 3'-monophosphate.
    Koivisto P; Hemminki K
    Carcinogenesis; 1990 Aug; 11(8):1389-92. PubMed ID: 2387026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple chromatographic systems permitting both DNA purification and separation of 2'-deoxyribonucleoside 3'-monophosphates as substrates for 32P-postlabelling studies.
    Polverelli M; Berger M; Odin F; Cadet J
    J Chromatogr; 1993 Apr; 613(2):257-65. PubMed ID: 8491811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabelling of 7-methyl-dGMP ring-opened 7-methyl-dGMP and platinated dGpdG.
    Hemminki K; Peltonen K; Mustonen R
    Chem Biol Interact; 1990; 74(1-2):45-54. PubMed ID: 2322952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A; Staffas J; Hemminki K
    Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development, validation and application of a 32P-postlabelling assay to quantify O6-methylguanine in human DNA.
    Povey AC; Cooper DP
    Carcinogenesis; 1995 Jul; 16(7):1665-9. PubMed ID: 7614705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.